Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q2 2024 Earnings

23MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-43.97

-25.3

-6.63

12.05

Details

Expected EPS

5.4918635728

Actual EPS

-43.974849408384

Surprise EPS

-49.47

Surprise Percent

+900.73%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of -43.974849408384 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.